NRX Pharmaceuticals, Inc. Share Price
NRXPNRX Pharmaceuticals, Inc. Stock Performance
Open $3.81 | Prev. Close $3.87 | Circuit Range N/A |
Day Range $3.73 - $3.99 | Year Range $1.64 - $5.05 | Volume 18,009 |
Average Traded $3.83 |
NRX Pharmaceuticals, Inc. Share Price Chart
About NRX Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.
NRX Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
10-Jun-26 | $3.81 | $3.75 | +0.00% |
10-Jun-26 | $3.81 | $3.75 | -2.72% |
09-Jun-26 | $4.35 | $3.86 | -10.96% |
08-Jun-26 | $4.21 | $4.33 | +4.46% |
05-Jun-26 | $4.08 | $4.15 | +2.47% |
04-Jun-26 | $3.97 | $4.05 | +0.50% |
03-Jun-26 | $3.61 | $4.03 | -12.58% |